Objective. A favorable incidence and severity of graft-vs-host disease is observed in patients transplanted with banked, unrelated, HLA-mismatched umbilical cord blood (UCB) grafts, while the incidence of malignant relapse remains low. CTLA-4 mediates negative T-cell signaling and may contribute to the development of allogeneic tolerance. In this study, we compared protein and mRNA expression of CTLA-4 in stimulated UCB and adult peripheral blood T cells. Materials and Methods. T cells were isolated from UCB and adult peripheral blood and stimulated with anti-CD3 and anti-CD28 monoclonal antibodies. Cells were immunostained and analyzed by flow cytometry for both surface and intracellular expression of CTLA-4 in the presence and absence of cyclosporin A, and kinetics of CTLA-4 expression compared. CTLA-4 mRNA expression was measured using quantitative real-time polymerase chain reaction. NFAT1 protein levels were measured by Western blot analysis.
Allogeneic transplantation using unrelated donors is limited by graft-vs-host disease (GVHD) mediated by donor T cells recognizing major and minor histocompatibility antigens on recipient antigen-presenting cells [1, 2] . Clinical efforts are currently underway to ameliorate GVHD, while preserving the T-cell repertoire to fight infection and disease relapse. The use of banked unrelated umbilical cord blood (UCB) for allogeneic transplant is a promising approach because the incidence and severity of GVHD is favorable compared with that in recipients of matched unrelated grafts from adult donors, despite infusion of HLA disparate grafts [3] [4] [5] [6] [7] [8] [9] . Graft-vs-leukemia effects also are mediated by T cells, as recipients of T-cell-depleted allografts suffer increased rates of relapse [10] [11] [12] . Interestingly, studies thus far have not demonstrated an increase in the incidence of relapse following unrelated UCB stem cell transplant [8, 9] , suggesting that the graft-vs-leukemia effect of these grafts remains intact despite the low incidence of GVHD.
Efficient T-cell activation requires primary T-cell receptor stimulation and a second costimulatory signal delivered via CD28. CD28 engagement by the B7 molecules (B7-1 and B7-2) expressed on antigen-presenting cells, in conjunction with T-cell receptor-generated signals, results in enhanced T-cell proliferation and cytokine production [13, 14] . Similar CD28 surface expression and costimulatory function have been demonstrated in UCB and adult T cells [15, 16] . CTLA-4, which is expressed exclusively on activated T cells, binds both B7-1 and B7-2 with a 10-fold to 20-fold higher affinity [17] [18] [19] , thereby competing with CD28 for its activating ligand. Evidence from CTLA-4 gene-deleted mice as well as antibody-blocking studies clearly indicate that CTLA-4 mediates negative T-cell signaling [20, 21] .
Many studies support a critical role for CTLA-4 in the regulation of tolerance [19, 20, 22] . Compelling evidence for this is the dramatic, rapidly fatal lymphoproliferative disorder observed in CTLA-4 gene-deleted mice [21, 23] . Additional support is derived from murine models of autoimmunity, including experimental autoimmune encephalitis and autoimmune diabetes, in which CTLA-4 blockade promotes disease progression [24] [25] [26] [27] . In humans, a base-exchange polymorphism within the gene encoding CTLA-4 is linked with the development of several autoimmune disorders [19, [28] [29] [30] [31] . The CD28/CTLA-4/B7 pathway also has been implicated in the pathogenesis of GVHD. Murine transplant studies clearly indicate that CD28 costimulation exacerbates GVHD while CTLA-4 engagement can attenuate its severity [32] [33] [34] .
In addition to its role in allograft tolerance, CTLA-4 blockade enhances antitumor immune responses in mice [35] [36] [37] [38] [39] . Leach et al. [40] demonstrated that a CTLA-4-blocking antibody given to mice injected with tumor cells inhibited tumor growth, even when the tumor cells did not express B7. When subsequently reinjected with tumor cells, these mice were protected against tumor regrowth, demonstrating maintained immunologic memory after CTLA-4 blockade.
We compared CTLA-4 expression by activated UCB and adult peripheral blood T cells during primary stimulation. We observed that activated UCB T lymphocytes expressed significantly less CTLA-4, including both cell surface and total protein expression, as well as less CTLA-4 mRNA upon stimulation compared with adult controls.
Materials and methods

Cells
After obtaining informed consent, human UCB was collected into sterile bags containing citrate dextrose (Allegiance, Deerfield, IL, USA) after delivery of full-term neonates of healthy mothers and processed as described. Peripheral blood mononuclear cells were enriched for T cells by negative selection using the monoclonal antibodies (mAbs) anti-CD11b, anti-CD19, anti-CD16, and anti-CD56 (Pharmingen, San Diego, CA, USA), followed by antiimmunoglobulin G magnetic bead depletion (Dynal, Lake Success, NY, USA). This purification method results in greater than 90% purity of CD3 ϩ T cells when assessed by flow cytometry, as previously described [41] .
Cell culture and stimulation T cells either were cultured in RPMI-1640 (Gibco BRL, Gaithersburg, MD, USA) with 10% fetal bovine serum (Gibco BRL) and antibiotic/antimycotic (Sigma, St. Louis, MO, USA) in 48-well plates at a density of 2 ϫ 10 6 cells/mL or were stimulated with plate-bound anti-CD3 mAb (Hit3a; Pharmingen) at 1 g/mL and soluble anti-CD28 mAb (CD28.2; Pharmingen) at 5 g/mL for the indicated time period. Where indicated, 1 g/mL CsA (Sigma) was added at the time of plating.
Flow cytometry
Cells were immunostained with panels of fluorochrome-conjugated mAbs, as well as isotype-matched controls. Anti-CD45RA and anti-CD45RO were purchased from Caltag (Burlingame, CA, USA). Anti-CD3, anti-CD69, and CTLA-4 were purchased from Becton-Dickinson (San Jose, CA, USA). For intracellular staining, lymphocytes were permeabilized with FACS Permeabilizing Solution (Becton-Dickinson) prior to staining. Data were acquired using an Elite ESP flow cytometer (Coulter, Miami, FL, USA). Compensation and analysis were performed using WinList software (Verity Software House, Topsham, MN, USA).
Real-time polymerase chain reaction
To generate template DNA for the CTLA-4 standard curve, the plasmid pCTLA-4(h)·Ig/REP7 ␤ [42] was generously provided by M. Tykocinski (Department of Pathology, University of Pennsylvania). The sequence encoding the two extracellular domains of hCTLA-4 was liberated by Hin d III digestion, and the resulting fragment was gel purified. To generate template DNA for the actin standard curve, I.M.A.G.E. CloneID 61151 in pBluescript SK was purchased from American Type Culture Collection (Manassas, VA, USA). The coding sequence was liberated by digestion with Eco RI/ Xho I, followed by gel purification.
Primer pairs were selected with the assistance of Oligo 6.4 (Molecular Biology Insights, Cascade, CO, USA). Oligonucleotide primers for polymerase chain reaction (PCR) were designed to cross at least one intron and were purchased from Sigma-Genosys (Woodlands, TX, USA). The CTLA-4 primer sequences used were 5 Ј -CACAAGGCTCAGCTGAACCT-3 Ј and 5 Ј -AGGTGC-CCGTGCAGATGGAA-3 Ј for an amplicon length of 294 bp. The actin primer sequences used were 5 Ј -CGGGAAATCGTGCGT-GACAT-3 Ј and 5 Ј -CTAGAAGCATTTGCGGTGGA-3 Ј for an amplicon length of 492 bp. Primers were used at a concentration of 1 M for real-time PCR.
Resting T cells and T cells cultured for 22 hours with platebound anti-CD3 and soluble anti-CD28 were harvested, and total RNA was isolated by acid phenol extraction [43] . Total RNA was reverse transcribed with oligo-dT using Superscript II (Gibco BRL) following the manufacturer's instructions. Resulting cDNAs were subjected to quantitative real-time PCR using a Roche Light Cycler (Roche, Indianapolis, IN, USA). Double-stranded product was detected using SYBR Green I (Roche) following the manufacturer's instructions. Products of real-time PCR were run on agarose gels to assess amplicon size, and representative amplified product was sequenced for confirmation.
Western blot analysis T cells were lysed and analyzed for NFAT1 expression as previously described [41] . Band intensities were quantified by densitometry scanning on Sci Scan 5000 (U.S. Biochemical, Cleveland, OH, USA) and normalized for loading with the actin band. 
Proliferation assays
Results
Induction of cell surface and total cellular CTLA-4 expression is reduced in UCB T cells
We used flow cytometry to compare induction of CTLA-4 expression by gated CD3 ϩ UCB and adult T cells after 48 hours of primary stimulation. Although expression of the activation marker CD69 was similar in activated UCB and adult T cells (data not shown), fewer UCB CD3 ϩ T cells were induced to express CTLA-4 than adult: 6.8% Ϯ 1.3% UCB vs 21.4% Ϯ 2.9% adult CD3 ϩ T cells (Fig. 1A) . Moreover, surface CTLA-4 expression was reduced in both CD3 
CD45RA
ϩ and CD3 ϩ CD45RO ϩ T cell subsets also were decreased compared to adult: 6.6% Ϯ 1.4% in UCB vs 10.8% Ϯ 1.9% in adult and 7.2% Ϯ 2.4% in UCB vs 19.4% Ϯ 2.9% in adult, respectively (Fig. 1B and C) . Reduced CTLA-4 levels therefore reflects a deficiency in expression rather than a simple numerical predominance of the CD3 ϩ
ϩ population in UCB T cells.
Only a small proportion of CTLA-4 is expressed on the cell surface, with substantial amounts located in subcellular clathrin-coated vesicles [44, 45] . Intracellular staining for CTLA-4 was performed to assess total cellular expression of CTLA-4, which was noted to be similarly decreased, with 47.6 % Ϯ 2.1% adult compared to 22.9% Ϯ 3.7% UCB CD3
ϩ T cells expressing CTLA-4 (Fig. 1D) . Mean fluorescence intensity of CTLA-4 staining also was reduced in UCB T cells compared to adult (Table 1) .
To determine if the reduced CTLA-4 expression by UCB CD3 ϩ T cells reflects a difference in the timing of CTLA-4 induction between cord and adult T cells, we examined the kinetics of CTLA-4 induction during primary T-cell stimulation. UCB and adult T cells were stimulated with anti-CD3 and anti-CD28 for 96 hours, and both surface and intracellular staining analyses were performed at 24-hour increments. In UCB T cells, CTLA-4 induction was severely impaired at early time points (Fig. 2) . Proportion of T cells expressing CTLA-4 in UCB was less than half that measured in adults at the previously described 48-hour plateau of CLTA-4 induction [46] . Although UCB T-cell surface CTLA-4 remained low up to 96 hours, intracellular CTLA-4 rose in UCB T cells and approached adult levels by 72 hours (Fig. 2) .
CTLA-4 mRNA expression is reduced in stimulated UCB T cells
With observations of surface and intracellular reduced CTLA-4 protein expression in stimulated UCB T cells at early time points, we hypothesized that reduced CTLA-4 protein expression might be caused by reduced CTLA-4 mRNA expression in UCB T cells. Real-time PCR analysis was performed to compare CTLA-4 mRNA expression in UCB versus adult T cells, after stimulation with plate-bound anti-CD3 and soluble anti-CD28 for 22 hours. CTLA-4 mRNA expression in unstimulated cells was negligible for both UCB and adult (data not shown). However, after 22 hours of stimulation, CTLA-4 message levels were significantly lower in UCB T cells compared to adult T cells, with levels in UCB averaging only 49% ( Ϯ 9.2 SEM, n ϭ 9; p ϭ 0.015) of that measured concomitantly in stimulated adult T cells. Thus, the reduced expression of CTLA-4 in UCB T cells at early time points during primary stimulation appears to result from reduced expression of CTLA-4 mRNA.
UCB T cells demonstrate an increased rate of autoproliferation
T cells isolated from CTLA-4 gene deleted mice demonstrate markedly increased proliferation in the absence of any external stimulation [21, 47] . We therefore measured proliferation in the absence of stimulation in UCB T cells and found that 3 H-thymidine incorporation by UCB T cells, after 24 hours of culture, was significantly greater than that of adult T cells: 2870 Ϯ 603 cpm for UCB vs 225 Ϯ 47 cpm for adult T cells (Fig. 3) . Thus, reduced CTLA-4 expression in UCB T cells is accompanied by an increased rate of autoproliferation.
CTLA-4 protein expression in both UCB and adult T cells is CsA sensitive
Given the presence of NFAT binding sites within the CTLA-4 promoter region [48] , we investigated the susceptibility of CTLA-4 expression to inhibition by a CsA, a known inhibitor of NFAT activation. Addition of CsA to cultures during primary stimulation significantly inhibited increase of total CTLA-4 protein expression in both UCB and adult T cells ( p ϭ 0.0039), with 54.6% Ϯ 18% inhibition in adult T cells vs 58.6% Ϯ 9.4% in UCB (Fig. 4) .
Concomitant measurement of NFAT1 protein expression by Western blot analysis showed reduced and delayed NFAT1 protein expression by UCB T cells compared to adult at all time points (Fig. 5) . Notably, induction of CTLA-4 protein expression followed NFAT1 induction in UCB by approximately 24 hours.
Discussion
Although the precise mechanisms underlying the favorable incidence of GVHD in UCB recipients have not yet been established, certain unique immunologic features render UCB optimal for use in the allogeneic transplant setting. Activated UCB lymphocytes produce lower amounts of several cytokines known to contribute to clinical GVHD, including interferon-␥ (IFN-␥ ), tumor necrosis factor-␣ (TNF-␣ ), and interleukin-2, demonstrate reduced generation of specific cytotoxic effectors, and, upon restimulation, a state of proliferative unresponsiveness is induced [49] [50] [51] . Furthermore, reduced NFAT1 protein expression by UCB T cells may be one mechanism underlying the blunted allogeneic responses observed in UCB T cells [41] .
Our studies demonstrate reduced surface and intracellular CTLA-4 expression in UCB T cells compared to adult controls. Interestingly, reduced and delayed CTLA-4 expression in UCB T cells followed reduced and delayed expression of NFAT1 in UCB by approximately 24 hours. We also observed reduced CTLA-4 mRNA expression, suggestive of reduced transcriptional activation. CTLA-4 gene activation may depend upon an NFAT binding site within the CTLA-4 promoter [48, 52] . Accordingly, CsA, a well-described inhibitor of NFAT, has been shown to inhibit CTLA-4 mRNA expression [53] . Reduced CTLA-4 expression also was observed in our studies in the presence of CsA, with equal inhibition noted in UCB and adult T cells (Fig. 4) .
We also showed that UCB T cells autoproliferate more rapidly than adult T cells when cultured in the absence of external stimulation. Interestingly, the degree of autoproliferation by UCB T cells (Fig. 3 ) mirrored that observed in T cells from CTLA-4 gene-deleted mice [21, 47] , suggesting that deficient CTLA-4 may result in an increased baseline activation status in the neonatal cells.
Animal studies have established that T cell costimulatory function is important in mediating GVHD [33] and that costimulatory blockade can both reduce GVHD [34] and promote engraftment [54] . Blockade of CD28/B7-mediated costimulation has been brought to the clinical setting in a recent human trial in which donor bone marrow was cocultured ex vivo with irradiated recipient T cells in the presence of CTLA-4 immunoglobulin. This graft manipulation resulted in significantly reduced donor T-cell responsiveness to recipient alloantigens, as well as reduced GVHD, in patients transplanted with HLA haplo-mismatched donors [55] . Thus, costimulatory blockade promises to be a useful tool to facilitate engraftment and reduce GVHD.
Observing reduced CTLA-4 expression in UCB T cells upon primary stimulation, one would expect increased GVHD after UCB T-cell transplantation. However, this is not the case. Several reports point toward a role for CTLA-4 in cytokine regulation, including IFN-␥ production [23, 56, 57] . As UCB T lymphocytes are severely impaired in IFN-␥ and TNF-␣ production after primary and secondary stimulation [58] , IFN-␥ and TNF-␣ production would not be expected to increase in UCB T cells, due to lack of downmodulation by CTLA-4 signaling. Moreover, in the murine model, absence/blockade of CTLA-4 in vitro and in vivo has been shown to result in bias toward a Th2 phenotype [20, 47] . Also, the observed higher rates of activation-induced cell death observed in UCB T lymphocytes after secondary stimulation [58] may be a contributing factor in the observed clinical observations of reduced GVHD after UCB transplant. Therefore, reduced expression of the key regulatory proteins CTLA-4 and NFAT1 may contribute to clinical observations of favorable UCB T-lymphocyte allogeneic responses.
